UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature

Cancers, 2022-03, Vol.14 (7), p.1770

2022

Volltextzugriff (PDF)

Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study

Frontiers in neuroscience, 2022-07, Vol.16, p.885291-885291

2022

Volltextzugriff (PDF)

Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future

Current radiopharmaceuticals, 2019-01, Vol.12 (2), p.93-95

2019

Volltextzugriff (PDF)

The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer

Cancers, 2021-08, Vol.13 (16), p.4155

2021

Volltextzugriff (PDF)

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy

Cancers, 2023-09, Vol.15 (18), p.4589

2023

Volltextzugriff (PDF)

Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

European journal of nuclear medicine and molecular imaging, 2023-07, Vol.50 (8), p.2246-2247

2023

Volltextzugriff (PDF)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms

Diagnostics (Basel), 2021-01, Vol.11 (2), p.192

2021

Volltextzugriff (PDF)

PET/MRI in Neuroendocrine Tumours: Blessings and Curses

Current radiopharmaceuticals, 2019-01, Vol.12 (2), p.96-97

2019

Volltextzugriff (PDF)

[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration

Bioengineering (Basel), 2023-08, Vol.10 (8), p.953

2023

Volltextzugriff (PDF)

Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers

Journal of clinical medicine, 2024-06, Vol.13 (11), p.3281

2024

Volltextzugriff (PDF)

External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images

Frontiers in medicine, 2023-02, Vol.10, p.1133269-1133269

2023

Volltextzugriff (PDF)

Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT

Nature reviews. Urology, 2015-09, Vol.12 (9), p.510-518

2015

Volltextzugriff (PDF)

18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma

The International Journal of Biological Markers, 2020-02, Vol.35 (1_suppl), p.42-46

2020

Volltextzugriff (PDF)

Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery

European journal of nuclear medicine and molecular imaging, 2023-07, Vol.50 (8), p.2244-2245

2023

Volltextzugriff (PDF)

Non ST ergometric variables in the diabetic patient and their prognostic significance

Monaldi archives for chest disease, 2015-12, Vol.74 (1)

2015

Volltextzugriff (PDF)

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

Diagnostics (Basel), 2021-11, Vol.11 (11), p.2068

2021

Volltextzugriff (PDF)

Beyond 68 Ga-labeled somatostatin analogues: is it time to say goodbye to [ 68 Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

European journal of nuclear medicine and molecular imaging, 2023-07, Vol.50 (8), p.2246

2023

Volltextzugriff (PDF)

High-grade endometrial cancer: value of [18F]FDG PET/CT in preoperative staging

Nuclear medicine communications, 2010-06, Vol.31 (6), p.506-512

2010

Volltextzugriff (PDF)

18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry

Current radiopharmaceuticals, 2018-01, Vol.11 (1), p.50-57

2018

Volltextzugriff (PDF)

Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin

The Journal of immunology (1950), 2008-07, Vol.181 (2), p.1460-1469

2008

Volltextzugriff (PDF)

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

Current radiopharmaceuticals, 2017-11, Vol.10 (3), p.195

2017

Volltextzugriff (PDF)

FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes

Current radiopharmaceuticals, 2017-08, Vol.10 (2), p.102

2017

Volltextzugriff (PDF)

B-cell depletion with obinutuzumab for the treatment of IgG4-related disease

European journal of internal medicine, 2023-10, Vol.116, p.155-156

2023

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(215)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(115)
Humans
(79)
Male
(46)
Patients
(35)
Middle Aged
(34)
Female
(33)
Radiology, Nuclear Medicine & Medical Imaging
(33)
Aged
(32)
Oncology
(28)
Tomography
(26)
Medicine
(25)
Medicine & Public Health
(24)
Nuclear Medicine
(24)
Prostate Cancer
(23)
Tumors
(23)
Positron Emission Tomography
(22)
Magnetic Resonance Imaging
(21)
Medical Imaging
(21)
Positron Emission
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature

Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study

Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future

The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy

Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms

PET/MRI in Neuroendocrine Tumours: Blessings and Curses

Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness

68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data

[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration

Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers

External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images

Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT

18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma

Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery

Non ST ergometric variables in the diabetic patient and their prognostic significance

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients

Beyond 68 Ga-labeled somatostatin analogues: is it time to say goodbye to [ 68 Ga]DOTA-conjugated peptides for neuroendocrine neoplasms?

High-grade endometrial cancer: value of [18F]FDG PET/CT in preoperative staging

18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry

Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes

B-cell depletion with obinutuzumab for the treatment of IgG4-related disease

Suchergebnisse filtern